Commercial Services Healthcare Sector

SBC Medical Group Holdings

Market Cap: US$397.9m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Faron Pharmaceuticals Oy

Market Cap: UK£292.9m

Operates as a clinical stage drug discovery and development company.

Rapport Therapeutics

Market Cap: US$394.9m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Tourmaline Bio

Market Cap: US$392.3m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

COMPASS Pathways

Market Cap: US$391.1m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

EyePoint Pharmaceuticals

Market Cap: US$390.9m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Verve Therapeutics

Market Cap: US$390.4m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

Fortrea Holdings

Market Cap: US$383.9m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Treace Medical Concepts

Market Cap: US$383.7m

A medical technology company, designs, manufactures, and markets medical devices in the United States.

AngioDynamics

Market Cap: US$382.1m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

Organogenesis Holdings

Market Cap: US$376.8m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Australian Clinical Labs

Market Cap: AU$575.1m

Provides pathology diagnostic services in Australia.

Humacyte

Market Cap: US$372.3m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Aura Biosciences

Market Cap: US$368.3m

A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.

Vigil Neuroscience

Market Cap: US$367.8m

A clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States.

Standard BioTools

Market Cap: US$362.5m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Mereo BioPharma Group

Market Cap: US$362.5m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Myriad Genetics

Market Cap: US$362.3m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

NIOX Group

Market Cap: UK£266.7m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

Olema Pharmaceuticals

Market Cap: US$353.1m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Emergent BioSolutions

Market Cap: US$352.8m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Rigel Pharmaceuticals

Market Cap: US$352.6m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Prothena

Market Cap: US$352.6m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Checkpoint Therapeutics

Market Cap: US$349.3m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Arcturus Therapeutics Holdings

Market Cap: US$347.1m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Benitec Biopharma

Market Cap: US$346.5m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Clinuvel Pharmaceuticals

Market Cap: AU$532.6m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

TruBridge

Market Cap: US$344.0m

Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

Erasca

Market Cap: US$342.8m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Anbio Biotechnology

Market Cap: US$340.2m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Absci

Market Cap: US$339.3m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

aTyr Pharma

Market Cap: US$338.2m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

ClearPoint Neuro

Market Cap: US$338.1m

Operates as a medical device company primarily in the United States.

SNDL

Market Cap: US$337.1m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

CytomX Therapeutics

Market Cap: US$335.6m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Nano-X Imaging

Market Cap: US$334.4m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.